WMA Healthcare Partners
WMA Healthcare Partners provides mergers and acquisitions services to healthcare services companies. Its stated service model includes sell-side process support, buy-side acquisition support, and markets spanning home health, staffing, behavioral health, pharmacy, and related healthcare services.
What stands out about WMA Healthcare Partners
WMA Healthcare Partners publicly describes a healthcare-focused M&A service model for small and mid-sized companies, including owner/operator-led businesses. Its published transaction archive lists examples across several healthcare subsectors and U.S. states, while the cited homepage does not state a defined geographic coverage territory.[1][2][3][4][5][6]
What does WMA Healthcare Partners do?
WMA Healthcare Partners provides mergers and acquisitions services to healthcare services companies. The founders are described as having started, acquired, managed, and sold healthcare service companies. WMA states that its model is designed for owner/operator-led companies in smaller to mid-markets.[1][2]
WMA’s sell-side process includes strategic marketing planning, negotiation of business terms, due diligence through data-room services, and execution of closing documents. Its buy-side process can support target identification, a single acquisition stage, or a full turnkey managed acquisition solution.[3][4]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring WMA Healthcare Partners?
An owner evaluating WMA can assess the firm’s stated focus on small and mid-sized healthcare companies, its stated experience with owner/operator-led companies, and the scope of its published sell-side process. The transaction archive provides examples across healthcare services and multiple states, but the cited archive does not populate transaction dates or name acquiring companies. Owners should confirm the current geographic coverage, buyer universe, engagement economics, valuation methodology, contracting entity, legal and regulatory structure, diligence process, and the team assigned to an engagement.[1][2][3][5]
What are the engagement fees, success-fee terms, minimums, exclusivity provisions, and termination rights
Which recent transactions can be discussed with dates, buyer categories, and seller references
What size transactions and clients does WMA Healthcare Partners focus on?
WMA publicly lists Medicare and Medicaid, home health, hospice, home infusion, private duty, DME services, therapy staffing, travel nursing, per diem and contract staffing, respiratory therapy, ancillary healthcare staffing, locum tenens, physician house calls, specialty pharmacy, and behavioral health among its markets or service areas.[1]
The official transaction archive lists a Private Texas Medicaid Home Care Company described as a $5M agency, a Texas Home Health Agency described as a $3.5M Medicare HHA, and an Ohio Home Health Agency described as a $1.5M Medicare HHA.
The archive also lists an Illinois Medicare Home Health Agency described as an $8M agency recapitalization, Virginia Mental Health Services described as $1M mental health services, and Texas Pediatric Home Care described as a $2M agency.
Additional entries include Travel Nurse Company transactions described as a $28M company and a $6M company.[5]
The firm describes both sell-side and buy-side healthcare transaction support. Its stated sell-side activities include marketing, negotiation, diligence through data-room services, and closing-document execution. Its buy-side process ranges from target identification to a single acquisition stage or a full turnkey managed acquisition solution.[3][4]
What does WMA Healthcare Partners publicly disclose about fees, process and engagement terms?
The cited transactions-completed page displays a transaction-date column but does not populate transaction dates for the listed examples. That page identifies the acquiring company as Private for the listed examples and does not disclose named acquiring-company identities for those examples.
The cited healthcare-business-listings page asks visitors to call or email for an updated current listing of represented companies and does not display identifiable active listings on that page. The cited official homepage does not state a defined geographic coverage territory for WMA Healthcare Partners.[1][5][6]
The official buying page states that WMA Healthcare Partners is a subsidiary of Wyatt Matas. The sources cited for this profile do not establish a firm-level broker-dealer, investment-adviser, or other regulatory registration.[4]
WMA publicly describes a sell-side process covering strategic marketing planning, negotiation of business terms, due diligence through data-room services, and execution of closing documents. Its buy-side process can support target identification, a single acquisition stage, or a full turnkey managed acquisition solution.[3][4]
Questions to ask before hiring WMA Healthcare Partners
What is WMA's current geographic coverage and buyer universe?
What are the engagement fees, success-fee terms, minimums, exclusivity provisions, and termination rights?
Which recent transactions can be discussed with dates, buyer categories, and seller references?
What valuation methodology and normalized earnings adjustments will be used?
Which legal entity contracts with the seller, and what role does Wyatt Matas play?
How are confidentiality, licensing, payer, change-of-control, and Medicare/Medicaid diligence issues handled?
What current companies are represented for sale?
Sources & research notes
- Official website / firm overview
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Transaction / portfolio evidence
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.